SQZ - SQZ Biotechnologies GAAP EPS of -$0.75 misses by $0.04 revenue of $2.87M misses by $2.06M May, 10 2022 05:28 PM SQZ Biotechnologies Company SQZ Biotechnologies press release (NYSE:SQZ): Q1 GAAP EPS of -$0.75 misses by $0.04. Revenue of $2.87M (-47.3% Y/Y) misses by $2.06M. For further details see: SQZ Biotechnologies GAAP EPS of -$0.75 misses by $0.04, revenue of $2.87M misses by $2.06M